NEW YORK (Reuters) - Healthcare deals will rebound this year after a weak 2012, with providers of innovative technologies, cancer treatments and diagnostics being the most likely targets, the founder and managing partner of healthcare-focusedsaid.Samuel Isaly, who manages and advises healthcare ... (Publication: Reuters Hedgeworld)
↧